… that there was a non-significant increasing dose response for thyroid cancer, with an ERR/Gy
of … Tables 3 and 4 demonstrate that the dose response for PTC had borderline significant …

… treatment for thyroid cancer are difficult to assess since the number of thyroid cancer patients
… ) was evaluated in a European cohort of thyroid cancer patients. A common database was …

… Thyroid cancers are a diverse group of malignant disorders ranging from indolent
micropapillary carcinoma, which has no effect on life expectancy, to anaplastic tumours, which are …

… ) is sufficient to treat differentiated thyroid cancer (DTC) even … was to evaluate the response
to LD and high-dose (HD) RAI … guidelines of the American Thyroid Association in Korean …

… the risk of developing thyroid cancer. Actual and possible … radiation doses to the thyroid and
corresponding cancer … a range of doses to the thyroid, and the risk for cancer is addressed …

… between radiation dose and risk of thyroid cancer, they are limited by their retrospective
design and the fact that radiation doses were estimated, in part, from ecologic models. …

… ) thyroid cancer, (4) to investigate further the dose–response relationship between radiation
dose to the thyroid and the development of thyroid cancer, and … dose–response at low doses. …

… The relation between lobe-specific thyroid-radiation dose and thyroid-cancer risk was …
whether risk of thyroid cancer increased with rising radiation dose across the whole dose range in …

… thyroid … thyroid effe due to chemically induced thyroid-pituity disruption are presumed to
be relevant to humans; 4) linear dose-response considerations are applied to thyroid cancer …

… radiation dose and thyroid cancer. Since the thyroid is not often in the direct field of exposure,
the actual dose is usually hard to determine, especially in the clinical setting. The lowest …